Sinuchron

Product NDC
44911-0525
Requested package NDC
44911-0525-1
11-digit product format
449110525
Labeler code
44911
Product ID
44911-0525_ecdef486-9d14-4945-85da-de3bf8370ee6
Type
HUMAN OTC DRUG
Nonproprietary name
Arsenicum Album, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Sepia, Thuja Occidentalis
Dosage form
LIQUID
Route
ORAL
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2020-02-24
Marketing end
2025-02-17
Substance
ANEMONE PRATENSIS; ARSENIC TRIOXIDE; CALCIUM SULFIDE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; POTASSIUM DICHROMATE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG
Active strength
30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage44911-052544911-0525-1DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0525-12022-03-17C16284748780-1d6a99b39-ee4f-a426-e053-dadaa90af4c2Drug Facts
44911-0525-12022-01-28C16284748780-1d6a99b39-ee4f-a426-e053-dadaa90af4c2Drug Facts

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
44911-0525-14491105250130 mL in 1 BOTTLE, DROPPER (44911-0525-1) 30 ml2020-02-242025-02-17NoNoCurrent